Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ursofalk
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ursofalk 250mg capsules
0109010U0BCAAAB
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 1,816 |
|
Ursofalk 500mg tablets
0109010U0BCACBK
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 1,035 |
|
Ursofalk 250mg/5ml oral suspension
0109010U0BCABBE
|
Ursofalk | Ursodeoxycholic acid | Gastro-Intestinal System | 225 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.